The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2

Autoría

autor: Brian K. Shoichet, Melanie Ott, James S Fraser, Taha Y Taha, Patrick C O'Leary, Galen J Correy, Yusuke Matsui, Hua-Dong Chen, Moira M Rachman, Danielle L Swaney, Michael Matthay, Alicia L Richards, Alan Ashworth, Morgan E. Diolaiti, Rahul Suryawanshi, Nevan Krogan, Francisco José Zapatero-Belinchón, Mauricio Montano, Julia Rosecrans, R. Jeffrey Neitz, Yagmur Umay Doruk, Adam R Renslo